AGREEMENT – PATIENT ORGANIZATIONAgreement • January 24th, 2024
Contract Type FiledJanuary 24th, 2024This Agreement (“Agreement”) is entered into between Takeda Pharma A/S, “Delta Park 45, DK- 2665 Vallensbæk Strand - Denmark (Takeda”), CVR 16406899 and LYLE, Patientforeningen for Lymfekræft, Leukæmi og MDS, Banetoften 26, 4700 Næstved, DK, CVR DK31306833 (“Patient Organization”), both Takeda and Patient Organization are hereinafter referred to as “Party” or “Parties”.